More than half of Boomerang Ventures’ early-stage portfolio companies are led by women who are building innovative solutions across the connected health landscape.
These leaders are tackling some of healthcare’s most complex challenges while developing category-defining companies in musculoskeletal care, women’s health, digital therapeutics, respiratory wellness, metabolic monitoring, long-term care, and survivorship mental health.
In the coming months, we will feature each of these leaders in Q&A profiles, offering a deeper look at their origin stories, leadership philosophies, and growth strategies. This introductory piece provides a high-level view of the leaders and companies shaping the next era of connected health.
Together, these companies represent a new chapter of healthcare change grounded in outcomes, scalability, and evidence-based discipline.
A Studio + Fund Model Built for Impact
Founded in 2019, Boomerang Ventures is anchored at the intersection of venture capital and hands-on company creation. Headquartered in Indianapolis and operating nationally, Boomerang has built a distinctive niche at the convergence of connected health, clinical rigor, and synchronized Studio and Fund support. Our Midwest foundation reinforces disciplined execution, while our portfolio footprint extends across major healthcare markets nationwide.
“Our role in the Studio is to work alongside founders to translate promising innovations into scalable connected health companies,” said Audrey Beckman, Partner & Chief Innovation Officer, Boomerang Ventures. “Through close collaboration and structured commercialization support, we help de-risk early ideas, refine market pathways, and guide solutions toward meaningful impact across both healthcare and emerging wellness markets.”
“Our Fund targets early growth-stage companies with differentiated models, defensible market positions, predictable demand patterns, multiple growth levers, and strong management teams,” said Oscar Moralez, Founder & Managing Partner, Boomerang Ventures. “We invest in leaders who understand both the urgency and the economics of healthcare. These companies are not just innovative. They are built for sustainable growth and measurable outcomes.”
From concept through commercialization, our strategically aligned Studio and Fund approach enables founders to move faster, smarter, and with stronger structural foundations designed for long-term value creation.
Reimagining Musculoskeletal and Mobility Care
Musculoskeletal disorders remain one of the costliest burdens in healthcare. These leaders are tackling this challenge from distinct but complementary angles.
Heidi Ojha, Founder & CEO, Aware Health
Seed Stage, Fund Portfolio | San Francisco, CA
Aware Health reduces the high healthcare costs associated with musculoskeletal pain for self-insured employers by pairing physical therapy doctors with proprietary diagnostic algorithms to prevent unnecessary imaging and surgeries.
Jennifer Holmes, CEO, PrecisionCare AI
Pre-Seed Stage, Studio Portfolio | Indianapolis, IN
PrecisionCare AI is transforming manual therapy with Quantitative Soft Tissue Manipulation (QSTM®), a patented platform that delivers real-time, objective feedback and digital documentation—enabling personalized treatment and measurable outcomes.
Kathy Phlegar, CEO, KinetiTec™ (formerly Bedside Bike)
Pre-Seed Stage, Studio Portfolio | Indianapolis, IN
KinetiTec™ addresses a critical gap in inpatient mobility by objectively quantifying strength maintenance and activity progression. By transforming recumbent movement into measurable data, KinetiTec SPARK™ supports more informed clinical decisions around mobility readiness, discharge planning, and post-surgical recovery pathways.
Previously operating as Bedside Bike, the company rebranded to KinetiTec to align with its broader mission of propelling recovery and connecting care across the inpatient continuum.
Advancing Women’s Health and Restoring Dignity in Care
Healthcare has long overlooked or underfunded critical women’s health and long-term care challenges. These leaders are changing that narrative.
Lydia Zeller, President & CEO, Flyte® by Pelvital
Seed Plus Stage, Fund Portfolio | Eagan, MN
Flyte offers an FDA-cleared treatment for female urinary incontinence, delivering clinically validated, non-surgical outcomes comparable to surgery and redefining standards of care.
Alli Truttman, Founder & CEO, Wicked Technologies
Series A2 Stage, Fund Portfolio | Louisville, KY
Wicked Technologies developed the Wicked Smart Pad®, a reusable, sensorized incontinence solution for long-term care facilities that improves resident dignity, reduces pressure sore risk, delivers real-time data insights, and lowers environmental waste.
Jeri Judkins, CEO, WithYou Therapeutics
Pre-Seed Stage, Studio Portfolio | Indianapolis, IN
WithYou Therapeutics is transforming survivorship care by addressing one of the most overlooked and fastest-growing needs in oncology: the emotional and psychological recovery of cancer survivors. By combining evidence-based Acceptance and Commitment Therapy (ACT) with scalable digital technology, WithYou is positioned to become the leading platform for survivorship-focused digital therapeutics.
Expanding the Frontiers of Digital Therapeutics and Neuro-Informed Care
Another group of leaders is pushing the boundaries of neuroscience, artificial intelligence, and immersive technology to deliver preventive and non-invasive care.
Georgia Mitsi, CEO, Mirawell (formerly Biofeedback VRx)
Pre-Seed Stage, Studio Portfolio | Indianapolis, IN
Mirawell delivers real-time biofeedback via wearable sensing and adaptive VR to reduce pain and anxiety in children undergoing intensive medical treatment. The solution is non-pharmacologic, workflow-friendly, and designed for repeated use across multi-month treatment cycles.
Formerly Biofeedback VRx, the company recently rebranded to Mirawell to reflect its broader platform vision and expanding clinical applications.
Emily Mirro, Co-Founder & President, SynchNeuro
Seed Stage, Fund Portfolio | Philadelphia, PA
SynchNeuro is developing a non-invasive, EEG-based platform for real-time metabolic health monitoring, harnessing brainwave signals and advanced AI to provide preventive insights for individuals at risk of diabetes and related conditions.
Jean Ross, RN, Co-Founder, Primary Record
Pre-Seed Stage, Fund Portfolio | Fishers, IN
Primary Record simplifies medical information management for families with medically complex loved ones by centralizing health data to improve care coordination and navigation.
Across these companies, the common thread is intelligence. Data-driven intervention enables earlier action, personalized care, and empowered patients and families.
Strengthening Preventive and Respiratory Health
Prevention remains one of healthcare’s greatest untapped opportunities.
Nancy Wright, Co-Founder & CEO, Respiratory Health Technologies
Seed Stage, Studio Portfolio | Indianapolis, IN
Respiratory Health Technologies focuses on improving respiratory wellness through hyperthermic therapies. Its first product, SinuSauna®, represents a novel preventive approach in a market with an enormous annual burden.
Here, innovation meets scale, addressing widespread respiratory challenges with science-backed solutions.
The Future Is Being Built Now
These 10 leaders are not participating in the future of healthcare. They are architecting it.
Across our portfolio, these companies are advancing FDA-cleared devices, launching AI-enabled platforms, deploying measurable therapy tools, improving long-term care environments, and supporting emotional recovery for patients navigating some of life’s most difficult moments.
Boomerang Ventures is proud to support and invest in the leaders building the next generation of connected health innovation.
In the months ahead, we will feature individual profiles on each leader’s journey, exploring how they are transforming healthcare from concept to commercialization and the impact they are driving across the broader healthcare ecosystem.
